CAPGEMINI UNS.ADR 1/5/EO8 Capital Reinvestment Ratio
CAPGEMINI UNS.ADR 1/5/EO8 capital reinvestment ratio. CAPGEMINI UNS.ADR 1/5/EO8 (CGMA) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow (€2.48 Billion) in capital expenditures (€287.00 Million). Check CAPGEMINI UNS.ADR 1/5/EO8 (CGMA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of CAPGEMINI UNS.ADR 1/5/EO8 (2022–2025)
Capital reinvestment ratio of CAPGEMINI UNS.ADR 1/5/EO8 from 2022 to 2025. This chart tracks CAPGEMINI UNS.ADR 1/5/EO8's Capital Reinvestment Ratio across 4 annual periods. Also explore CAPGEMINI UNS.ADR 1/5/EO8 (CGMA) equity growth momentum to track the company's year-over-year net asset growth rate.
CAPGEMINI UNS.ADR 1/5/EO8 Capital Reinvestment Ratio by Year (2022–2025)
CAPGEMINI UNS.ADR 1/5/EO8 capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see CGMA cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | €2.48 Billion | €287.00 Million | ▼ -7.3% |
| 2024 | 0.12x | €2.53 Billion | €315.00 Million | ▲ +21.6% |
| 2023 | 0.10x | €2.52 Billion | €259.00 Million | ▼ -11.0% |
| 2022 | 0.12x | €2.52 Billion | €290.00 Million | — |